+44 (0) 20 3997 7634 | sales@fbkmed.com
Home > Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.
13/07/13
Share on social media:
25/03/24
Bleepa Feedback Medical Feedback PLC
21/03/24
21/02/24